Jinyu Bio (China) Performance
| 600201 Stock | 7.37 0.05 0.68% |
On a scale of 0 to 100, Jinyu Bio holds a performance score of 13. The company retains a Market Volatility (i.e., Beta) of -0.31, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Jinyu Bio are expected to decrease at a much lower rate. During the bear market, Jinyu Bio is likely to outperform the market. Please check Jinyu Bio's information ratio, total risk alpha, and the relationship between the coefficient of variation and jensen alpha , to make a quick decision on whether Jinyu Bio's current trending patterns will revert.
Risk-Adjusted Performance
13 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Jinyu Bio Technology Co are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Jinyu Bio sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Payout Ratio 0.5333 | Last Split Factor 1.3:1 | Ex Dividend Date 2024-07-15 | Last Split Date 2018-06-25 |
1 | High Growth Tech Stocks To Watch This December 2024 - Yahoo Finance | 12/04/2024 |
| Begin Period Cash Flow | 1.3 B |
Jinyu |
Jinyu Bio Relative Risk vs. Return Landscape
If you would invest 576.00 in Jinyu Bio Technology Co on September 13, 2024 and sell it today you would earn a total of 161.00 from holding Jinyu Bio Technology Co or generate 27.95% return on investment over 90 days. Jinyu Bio Technology Co is generating 0.4695% of daily returns and assumes 2.705% volatility on return distribution over the 90 days horizon. Simply put, 24% of stocks are less volatile than Jinyu, and 91% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Jinyu Bio Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Jinyu Bio's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Jinyu Bio Technology Co, and traders can use it to determine the average amount a Jinyu Bio's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1736
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | 600201 | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.71 actual daily | 24 76% of assets are more volatile |
Expected Return
| 0.47 actual daily | 9 91% of assets have higher returns |
Risk-Adjusted Return
| 0.17 actual daily | 13 87% of assets perform better |
Based on monthly moving average Jinyu Bio is performing at about 13% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Jinyu Bio by adding it to a well-diversified portfolio.
Jinyu Bio Fundamentals Growth
Jinyu Stock prices reflect investors' perceptions of the future prospects and financial health of Jinyu Bio, and Jinyu Bio fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Jinyu Stock performance.
| Return On Equity | 0.029 | ||||
| Return On Asset | 0.0098 | ||||
| Profit Margin | 0.12 % | ||||
| Operating Margin | 0.11 % | ||||
| Current Valuation | 6.95 B | ||||
| Shares Outstanding | 1.12 B | ||||
| Price To Book | 1.52 X | ||||
| Price To Sales | 6.11 X | ||||
| Revenue | 1.6 B | ||||
| Gross Profit | 831.37 M | ||||
| EBITDA | 281.76 M | ||||
| Net Income | 283.63 M | ||||
| Total Debt | 1.22 B | ||||
| Book Value Per Share | 4.70 X | ||||
| Cash Flow From Operations | 414.83 M | ||||
| Earnings Per Share | 0.15 X | ||||
| Total Asset | 6.87 B | ||||
| Retained Earnings | 3.16 B | ||||
About Jinyu Bio Performance
By analyzing Jinyu Bio's fundamental ratios, stakeholders can gain valuable insights into Jinyu Bio's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Jinyu Bio has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Jinyu Bio has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Jinyu Bio is entity of China. It is traded as Stock on SHG exchange.Things to note about Jinyu Bio Technology performance evaluation
Checking the ongoing alerts about Jinyu Bio for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Jinyu Bio Technology help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| About 20.0% of the company shares are owned by insiders or employees | |
| Latest headline from news.google.com: High Growth Tech Stocks To Watch This December 2024 - Yahoo Finance |
- Analyzing Jinyu Bio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Jinyu Bio's stock is overvalued or undervalued compared to its peers.
- Examining Jinyu Bio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Jinyu Bio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Jinyu Bio's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Jinyu Bio's stock. These opinions can provide insight into Jinyu Bio's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Jinyu Stock analysis
When running Jinyu Bio's price analysis, check to measure Jinyu Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jinyu Bio is operating at the current time. Most of Jinyu Bio's value examination focuses on studying past and present price action to predict the probability of Jinyu Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jinyu Bio's price. Additionally, you may evaluate how the addition of Jinyu Bio to your portfolios can decrease your overall portfolio volatility.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |